Imaging stem cell therapy for the treatment of peripheral arterial disease.
about
Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic ApplicationsmiRNA-130b is required for the ERK/FOXM1 pathway activation-mediated protective effects of isosorbide dinitrate against mesenchymal stem cell senescence induced by high glucose.Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation.Multimodality reporter gene imaging: Construction strategies and application.Functional probes for cardiovascular molecular imaging
P2860
Imaging stem cell therapy for the treatment of peripheral arterial disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Imaging stem cell therapy for the treatment of peripheral arterial disease.
@en
Imaging stem cell therapy for the treatment of peripheral arterial disease.
@nl
type
label
Imaging stem cell therapy for the treatment of peripheral arterial disease.
@en
Imaging stem cell therapy for the treatment of peripheral arterial disease.
@nl
prefLabel
Imaging stem cell therapy for the treatment of peripheral arterial disease.
@en
Imaging stem cell therapy for the treatment of peripheral arterial disease.
@nl
P2860
P1476
Imaging stem cell therapy for the treatment of peripheral arterial disease.
@en
P2093
Julia D Ransohoff
P2860
P304
P356
10.2174/157016112799959404
P50
P577
2012-05-01T00:00:00Z